Shandong Lukang PharmaceuticalLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 600789?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	6,078,332	0.676%
Institutions	29,427,499	3.27%
Private Companies	217,900,235	24.2%
General Public	645,263,566	71.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 28.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23.8%	Hualu Holdings. Co, Ltd	214,004,727	CN¥2.1b	0%	no data
1.21%	Wanjia Asset Management Co., Ltd.	10,893,619	CN¥104.8m	0%	0.15%
0.46%	CITIC Securities Company Limited, Asset Management Arm	4,156,956	CN¥40.0m	0%	0.04%
0.45%	Fullgoal Fund Management Co. Ltd.	4,079,077	CN¥39.2m	0%	0.01%
0.43%	Shandong Development & Investment Holding Group Co.,Ltd	3,895,508	CN¥37.5m	0%	no data
0.3%	The Vanguard Group, Inc.	2,670,490	CN¥25.7m	0%	no data
0.3%	Everbright Asset Management Co., Ltd.	2,651,541	CN¥25.5m	0%	0.29%
0.29%	China International Capital Corporation Hong Kong Asset Management Limited	2,593,908	CN¥25.0m	0%	0.13%
0.26%	Ai Song	2,358,617	CN¥22.7m	0%	no data
0.13%	Shanghai Guotai Junan Securities Asset Management Co., Ltd.	1,196,500	CN¥11.5m	0%	0.03%
0.1%	Dimensional Fund Advisors LP	916,708	CN¥8.8m	4.81%	no data
0.096%	Peng Xin	860,000	CN¥8.3m	49.3%	no data
0.057%	Wei Zhao	510,000	CN¥4.9m	49.3%	no data
0.057%	Kun Dong	508,900	CN¥4.9m	68.8%	no data
0.043%	Li Li	381,900	CN¥3.7m	0%	no data
0.034%	Jie Zhang	302,618	CN¥2.9m	0%	no data
0.034%	Xiao Cui	301,500	CN¥2.9m	0%	no data
0.031%	Lixin Tian	281,400	CN¥2.7m	0%	no data
0.022%	Haifeng Cao	200,000	CN¥1.9m	49.3%	no data
0.022%	Defeng He	199,997	CN¥1.9m	49.3%	no data
0.019%	Aiyu Wang	173,400	CN¥1.7m	0%	no data
0.016%	Harvest Fund Management Co. Ltd.	141,000	CN¥1.4m	0%	no data
0.0086%	CICC Fund Management Co., Ltd.	77,500	CN¥745.2k	0%	0.03%
0.0015%	China Universal Asset Management Company Ltd.	13,200	CN¥127.1k	0%	no data
0.00095%	China Merchants Fund Management Company Ltd.	8,500	CN¥82.1k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 18:24
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Lukang Pharmaceutical Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution